Edition:
United States

OraSure Technologies Inc (OSUR.OQ)

OSUR.OQ on NASDAQ Stock Exchange Global Select Market

12.57USD
29 Mar 2017
Change (% chg)

-- (--)
Prev Close
$12.57
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
274,112
52-wk High
$12.74
52-wk Low
$5.57

OSUR.OQ

Chart for OSUR.OQ

About

OraSure Technologies, Inc. (OraSure) is involved in the development, manufacture, marketing and sale of oral fluid diagnostic products and specimen collection devices using its technologies, as well as other diagnostic products, including immunoassays and other in vitro diagnostic tests that are used on other specimen types. The... (more)

Overall

Beta: 1.57
Market Cap(Mil.): $733.96
Shares Outstanding(Mil.): 57.66
Dividend: --
Yield (%): --

Financials

  OSUR.OQ Industry Sector
P/E (TTM): 36.58 34.27 30.15
EPS (TTM): 0.35 -- --
ROI: 11.12 12.76 13.05
ROE: 11.42 14.81 14.20

BRIEF-OraSure receives global fund classification to enable HIV self-test procurement

* OraSure Technologies Inc - OraSure receives global fund classification to enable HIV self-test procurement

Mar 01 2017

BRIEF-OraSure announces 2016 fourth quarter and full-year financial results

* OraSure announces 2016 fourth quarter and full-year financial results

Feb 08 2017

BRIEF-Orasure Technologies announces settlement of litigation with ancestry.comdna

* Says under a settlement and license agreement executed by parties, ancestry has agreed to pay DNA Genotek a settlement fee of $12.5 million

Feb 06 2017

BRIEF-Orasure Technologies appoints Stephen Tang as chairman of the board of directors

* Orasure Technologies Inc- appointment of Stephen S. Tang, as chairman of company's board of directors effective November 14, 2016

Nov 15 2016

More From Around the Web

Earnings vs. Estimates